Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-30

Clinical Trial Update: Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs

View source ↗

Summary

Alaunos Therapeutics reports long-term follow-up data from subjects treated with autologous T cells engineered with a Sleeping Beauty system to express TCRs, ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sleeping Beauty TCR autologous T-cell therapy

Snippet

Sponsor: Alaunos Therapeutics | Conditions: Gynecologic Cancer, Colorectal Cancer | Status: COMPLETED